CS235030B2 - Method of n-carboxyalkylpropylene resiude containg tripeptides production - Google Patents

Method of n-carboxyalkylpropylene resiude containg tripeptides production Download PDF

Info

Publication number
CS235030B2
CS235030B2 CS827906A CS790682A CS235030B2 CS 235030 B2 CS235030 B2 CS 235030B2 CS 827906 A CS827906 A CS 827906A CS 790682 A CS790682 A CS 790682A CS 235030 B2 CS235030 B2 CS 235030B2
Authority
CS
Czechoslovakia
Prior art keywords
proline
mol
compounds
benzyl ester
prolyl
Prior art date
Application number
CS827906A
Other languages
Czech (cs)
English (en)
Inventor
Francis R Pfeiffer
Original Assignee
Smithkline Beckman Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beckman Corp filed Critical Smithkline Beckman Corp
Publication of CS235030B2 publication Critical patent/CS235030B2/cs

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0821—Tripeptides with the first amino acid being heterocyclic, e.g. His, Pro, Trp
    • C07K5/0823—Tripeptides with the first amino acid being heterocyclic, e.g. His, Pro, Trp and Pro-amino acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cardiology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
CS827906A 1981-11-06 1982-11-05 Method of n-carboxyalkylpropylene resiude containg tripeptides production CS235030B2 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US31872181A 1981-11-06 1981-11-06

Publications (1)

Publication Number Publication Date
CS235030B2 true CS235030B2 (en) 1985-04-16

Family

ID=23239338

Family Applications (1)

Application Number Title Priority Date Filing Date
CS827906A CS235030B2 (en) 1981-11-06 1982-11-05 Method of n-carboxyalkylpropylene resiude containg tripeptides production

Country Status (25)

Country Link
EP (1) EP0080283B1 (de)
JP (1) JPS5890537A (de)
KR (1) KR880002594B1 (de)
AT (1) ATE17736T1 (de)
AU (1) AU562011B2 (de)
CA (1) CA1247085A (de)
CS (1) CS235030B2 (de)
DD (1) DD206553A5 (de)
DE (1) DE3268884D1 (de)
DK (1) DK480682A (de)
ES (1) ES8401447A1 (de)
FI (1) FI75175C (de)
GR (1) GR77368B (de)
HU (1) HU187808B (de)
IE (1) IE53982B1 (de)
IL (1) IL67070A (de)
NO (1) NO160081C (de)
NZ (1) NZ202232A (de)
PH (1) PH18708A (de)
PL (1) PL136098B1 (de)
PT (1) PT75769B (de)
RO (1) RO84706B (de)
YU (1) YU245582A (de)
ZA (1) ZA827816B (de)
ZW (1) ZW23282A1 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE174343T1 (de) * 1991-02-27 1998-12-15 Lacer Sa Antihypertensive n-(alpha-substituiertes pyridyl)-carbonyldipeptide
JP3068200B2 (ja) 1995-06-06 2000-07-24 ファイザー・インコーポレーテッド グリコーゲンホスホリラーゼ阻害剤としての置換ｎ−（インドール−２−カルボニル−）アミドおよび誘導体
MY114711A (en) 1995-06-06 2002-12-31 Pfizer Substituted n-(indole-2-carbonyl)-b-alanmamides and derivatives as antidiabetic agents
CA2224062C (en) * 1995-06-06 2001-09-04 Pfizer Limited Substituted n-(indole-2-carbonyl)-glycinamides and derivatives as glycogen phosphorylase inhibitors
US6277877B1 (en) 2000-08-15 2001-08-21 Pfizer, Inc. Substituted n-(indole-2-carbonyl)glycinamides and derivates as glycogen phosphorylase inhibitors
KR20040013679A (ko) * 2002-08-08 2004-02-14 현대산업개발 주식회사 실내 공기 상태 표시장치

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2480747A1 (fr) * 1980-04-17 1981-10-23 Roques Bernard Derives d'acides amines et leur application therapeutique

Also Published As

Publication number Publication date
KR880002594B1 (ko) 1988-12-03
IL67070A0 (en) 1983-02-23
PL136098B1 (en) 1986-01-31
NO160081C (no) 1989-03-08
FI823798A0 (fi) 1982-11-05
PT75769A (en) 1982-11-01
EP0080283A1 (de) 1983-06-01
ATE17736T1 (de) 1986-02-15
NO160081B (no) 1988-11-28
JPS5890537A (ja) 1983-05-30
KR840002372A (ko) 1984-06-25
NO823693L (no) 1983-05-09
RO84706A (ro) 1984-07-17
PT75769B (en) 1985-07-26
NZ202232A (en) 1985-08-16
AU9017382A (en) 1983-05-12
CA1247085A (en) 1988-12-20
GR77368B (de) 1984-09-11
DE3268884D1 (en) 1986-03-13
IE822647L (en) 1983-05-06
PH18708A (en) 1985-09-05
IL67070A (en) 1986-01-31
ZW23282A1 (en) 1983-02-23
DK480682A (da) 1983-05-07
IE53982B1 (en) 1989-05-10
ZA827816B (en) 1983-08-31
RO84706B (ro) 1984-09-30
FI75175B (fi) 1988-01-29
AU562011B2 (en) 1987-05-28
ES517144A0 (es) 1983-12-16
HU187808B (en) 1986-02-28
EP0080283B1 (de) 1986-01-29
DD206553A5 (de) 1984-02-01
FI823798L (fi) 1983-05-07
YU245582A (en) 1985-03-20
ES8401447A1 (es) 1983-12-16
FI75175C (fi) 1988-05-09
PL238893A1 (en) 1983-07-04

Similar Documents

Publication Publication Date Title
EP0183398B1 (de) Inhibitoren für Angiotensin umwandelndes Enzym, deren Herstellung und Verwendung als Pharmazeutika
JPH0346463B2 (de)
SI9620037A (sl) Novi trombinski inhibitorji
US4801609A (en) Mercapto-acylamino acid antihypertensives
IE56816B1 (en) Certain benzazocinone and benzazoninone derivatives,process for their preparation,pharmaceutical preparations containing them and their therapeutic use
EP0074787B1 (de) Auf der Niere aktive Dipeptide
DE4443390A1 (de) Neue dipeptidische p-Amidinobenzylamide mit N-terminalen Sulfonyl- bzw. Aminosulfonylresten
EP0110224A2 (de) Benzoylthioverbindungen, ihre Herstellung und Verwendung als Arzneimittel
CS235030B2 (en) Method of n-carboxyalkylpropylene resiude containg tripeptides production
EP0103496A1 (de) Acylalkylaminocarbonylsubstituierte Amino- und Iminosäureverbindungen
US4087520A (en) Lowering blood pressure with new L-3-(3,4-dihydroxyphenyl)-2-methyl-alanine peptides
CA1158236A (en) Process for the preparation of novel substituted phenylacetic acid amide compounds
US4456594A (en) N-Carboxyalkylproline-containing tripeptides
US4387049A (en) Adamantyl containing peptides
EP0322633B1 (de) Mercapto-acylaminosäure-Antihypertensiver
US4490386A (en) Phosphate salts of 1-[2-[(1-alkoxycarbonyl-3-aralkyl)-amino]-1-oxoalkyl]octahydro-1H-indole-2-carboxylic acids, preparation of, and medical compositions thereof
EP0058567B1 (de) Substituierte Acylderivate der Octahydro-1H-isoindol-1-carbonsäure und Ester
US4448972A (en) Adamantyl containing intermediates
US4400511A (en) 2-Substituted octahydropyrrolo(1,2-A)-pyrazine-3-carboxylic acids
US4758675A (en) 3-thiophene-substituted tyrosyl dipeptide amides
US4503043A (en) Substituted acyl derivatives of octahydro-1H-isoindole-1-carboxylic acids
US4386075A (en) Renally active tetrapeptides
EP0212550A2 (de) Substituierte Dipeptidamide
EP0086660B1 (de) In Nieren wirksame Tetrapeptiden
CA1279950C (en) Substituted dipeptide amides #2